Biznes · 26.08.19971 min czytania
Implantation or Injectable Dosage Form New Animal Drugs; Polysulfated Glycosaminoglycan
Automatyczne tłumaczenie lokalne · Oryginalny język źródła
Streszczenie
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Luitpold Pharmaceuticals, Inc. The NADA provides for intramuscular injection of polysulfated glycosaminoglycan for dogs for control of signs associated with noninfectious degenerative and/or traumatic arthritis of canine synovial joints.